Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Identifying Suspicious Skin Lesions with a Noninvasive, Painless Device

Published: Monday, October 28, 2013
Last Updated: Sunday, October 27, 2013
Bookmark and Share
VivaScope®cellular imaging devices from Caliber Imaging & Diagnostics.

One in five Americans will develop skin cancer. According to a 2007 study in Archives of Dermatology, more than 3.5 million skin cancers are diagnosed annually-more new cases than breast, prostate, lung and colon cancers combined.

One might think that most people wouldn't hesitate to consult a dermatologist or their general practitioner about any bump, mole or discoloration on their body, since many skin cancers can now be successfully treated if found sufficiently early.

It is surprising that anyone with a skin lesion would hesitate before seeking medical evaluation - one excuse people give is that if they ignore it, it will just go away. Why else do people wait? Some may honestly believe their moles are nothing to worry about.

Others are terrified that a biopsy would leave a scar, a concern that does hold some validity since the majority of skin lesions are benign, but until recently, could only be proven benign by performing a biopsy and examining the surgically removed tissue under a microscope.

One innovative company, Caliber Imaging & Diagnostics, led by CEO L. Michael Hone, has taken the steam out of that last excuse with their FDA-cleared VivaScope®cellular imaging devices.

These new tools allow physicians to biopsy and technicians to evaluate a patient's skin, at and below the skin surface, using imaging rather than surgical options.

Says Hone: "The best medicine with regard to skin cancer is prevention. One should always consider sun protection, apply SPF-30 every day and wear a hat and sunglasses outdoors. The second-best medicine is to consult one's health care provider immediately when one spots anything that might be the least bit questionable. And when a doctor is consulted, ask if they have a noninvasive way to biopsy skin. Doctors should want to provide patients with a painless, noninvasive optical skin biopsy in lieu of the traditional biopsy to help them make a diagnosis."

The company is already marketing its VivaScope systems, including two handheld VivaScopes, the 1500 and 3000, and the VivaScope 2500 for use in the operating room. Another advantage: no waiting. Obtaining the image takes only five to 10 minutes.

"Our technology can image down into the entire lesion, layer by layer, and immediately help doctors eliminate or diagnose a variety of skin diseases and disorders," says Hone.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,900+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Scientists Identify Unique Genomic Features in Testicular Cancer
The findings may shed light on factors in other cancers that influence their sensitivity to chemotherapy.
Smart Patch Releases Blood Thinners When Needed
Researchers have developed a smart patch that activelly monitors a patient's blood and releases blood thinning drugs when necessary.
First-Ever Capsule to Treat Hemophilia
In the near future, hemophiliacs could be able to treat their disease by simply swallowing a capsule.
Enhancing CRISPR to Explore Further
Researchers have developed sOPTiKO, a more efficient and controllable CRISPR genome editing platform.
New Compound to Reduce Tumor Growth
Researchers at Stanford found that a new cell surface receptor they created is effective at inhibiting cancer growth in mice.
Long-Lasting Pill to Fight Malaria
An ultra-long acting pill has been developed to offer a new hope in eliminating malaria.
History of Cells Told Through MEMOIR
MEMOIR technique developed by CalTech researchers enables the life history of cells to be read.
Synthetic Protein Captures DNA Events Leading to Cancer
A team of scientists have developed new technology allowing them to identify molecular intermediates that can drive genetic change.
Precision Medicine for Rheumatoid Arthritis
Researchers identify gene mechanism that increases rheumatoid arthritis risk in susceptable individuals.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!